MicroRNAs Unleash Aggressive Prostate Cancer

Prostate cancer cells can transform into a more aggressive form when they stop responding to hormone therapy. This transformation leads to the development of neuroendocrine prostate cancer, which is a highly aggressive subtype with limited treatment options. Researchers have found that a specific type of cell in the tumor environment, called tumor-associated macrophages, plays a crucial role in this transformation. These cells release exosomes, which are like tiny messengers that can carry signals to other cells.

One of these signals is a microRNA called miR-142-5p. This microRNA can suppress the activity of a gene called RERG, which normally helps to prevent the transformation of prostate cancer cells into a more aggressive form. When RERG is suppressed, it can activate a pathway that promotes the growth and spread of cancer cells.

In experiments, researchers found that miR-142-5p can enhance the proliferation, migration, and invasion of prostate cancer cells, while also promoting their transformation into a more aggressive form. On the other hand, increasing the activity of RERG can reverse these effects.

The researchers also found that RERG is often underexpressed in aggressive prostate cancer cells and tissues. When they knocked down RERG in a mouse model, they observed a significant increase in tumor growth and transformation.

These findings suggest that targeting the RERG pathway may provide a new approach to treating aggressive prostate cancer. By understanding how tumor-associated macrophages and microRNAs contribute to the transformation of prostate cancer cells, researchers can develop more effective therapies to combat this disease.